Open AccessJournal Article
Monoclonal antibodies in the diagnosis and treatment of malignant conditions.
About:
This article is published in Surgery.The article was published on 1986-01-01 and is currently open access. It has received 20 citations till now. The article focuses on the topics: Monoclonal antibody.read more
Citations
More filters
Patent
Antibody conjugates reactive with human carcinomas
TL;DR: The BR96 antibody as mentioned in this paper is a single-chain immunotoxin that is reactive with a cell membrane antigen on the surface of human carcinoma cells and displays a high degree of selectivity for cancer cells and possess the ability to mediate antibodydependent cellular cytotoxicity and complement-dependent cytotoxin activity.
Patent
Monoclonal antibody to novel antigen associated with human tumors
TL;DR: In this article, a monoclonal antibody which binds strongly to a protein antigen associated with human tumors, including carcinomas of the colon, breast, ovary and lung, as well as melanomas and sarcomas, was presented.
Patent
Methods and compositions for diagnosing carcinomas
TL;DR: In this paper, the discovery of soluble forms of mesothelin polypeptides, including MRA, has been addressed, and a nucleic acid sequence encoding MRA and an MRA variant is provided.
Patent
Antibodies reactive with human carcinomas
TL;DR: In this article, the authors describe a set of antibodies that are reactive with a cell membrane antigen on the surface of human carcinoma cells and possess the ability to mediate ADCC and CDC activity.
Patent
Monoclonal antibody to human carcinomas
TL;DR: In this paper, a novel monoclonal antibody reactive with human carcinoma cells is presented. But the antibody is not suitable for use with other types of tumors such as lymphomas, sarcomas, or melanomas.